Reliable Brokers
Online Investing
Alerts & Analysis
Easy Trading

Genflow Biosciences jumps 17% again on OTCQB application

The last time this effect faded away again - maybe more luck this time, eh?

Update : 06 Jun 2023, 04:24 PM

Genflow Biosciences (LON: GENF) is an interesting example of how different markets value the same thing differently. This is something we do need to understand - not just because of the effect it can have on a stock like Genflow.

We would think - we should think - that stock markets are entirely rational. Yet that's simply not true because people are not entirely rational. As humans aren't then so are groups of humans not rational. This can be seen as a killer blow against the very idea of market economies of course but that's not quite true. Bureaucrats and politicians can be even more irrational than groups of humans dealing with their own money. 

Given that we do therefore have fashions and cultural effects these can vary across different markets. The investors in them are different groups of people after all, therefore the idea of different beliefs shouldn't be too difficult. Further, we find that this is so too. Exactly the same business can be differently valued in two different stock markets. So, if a stock that is currently listed in one such market then moves on to another we might well see a change in that valuation and price.

Genflow Biosciences share price from London Stock Exchange

That jump back last month came from Genflow's OTCQB announcement. As we can see that effect also faded away pretty quickly but attention has been drawn back to it today.

The OTCQB is, well, a little bit, like AIM here in London. For smaller and more experimental companies, that aren't quite ready for NASDAQ yet. OK - but there are two types of stock that the OTCQB tends to value more highly than London does. High tech companies and pharma development. Genflow fits into that second. 

Yes, it might seem strange that the New York markets will value the same company more highly. The same prospects, same cashflows, same capital requirements can often be more highly valued there than here. So, if - as Genfloiw is doing - there's a proposal to gain a listing there then we might well see an uprating of the shares. It's a fortelling of the increased buying expected when - if perhaps - the stock lists there. 

This also shows us that markets are forward looking. The actual arrival on the NY exchange might not produce any price movement at all, it all having happened in the run up. Or, as that old adage goes, buy the rumour and sell the fact. 

We would expect - expect only, this is not a prediction - continued volatility in Genflow shares until that OTCQB listing actually arrives. At which point we'll all be able to see what the real effect is.

Top Brokers